Revenue
$8.3M
▼ 71.6% YoY
Net Income
-$299.8M
▼ 74.3% YoY
EPS
$-0.54
▼ 125.0% YoY
Cash
$1.4B
▼ 47.7% YoY
FY 2026 · As of 2026-03-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Venker Eric President & Immunovant CEO | Vest | Aug 28, 2026 | 200.0K | $3.85 | $770K | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell | Aug 28, 2026 | 166.2K | $35.63 | $5.92M | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell | Aug 28, 2026 | 33.8K | $36.44 | $1.23M | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 21, 2026 | 144.8K | $3.85 | $557K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 21, 2026 | 144.8K | $36.48 | $5.28M | Form 4 ↗ |
Pulik Richard CFO | Sell tax | Aug 20, 2026 | 5.7K | $36.84 | $212K | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell tax | Aug 20, 2026 | 13.9K | $36.84 | $512K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 20, 2026 | 17.5K | $3.85 | $67K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 20, 2026 | 17.5K | $37.30 | $653K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 19, 2026 | 172.9K | $3.85 | $666K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 19, 2026 | 172.9K | $37.17 | $6.43M | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 18, 2026 | 105.1K | $3.85 | $405K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 18, 2026 | 105.1K | $36.59 | $3.85M | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 18, 2026 | 31.8K | $3.85 | $122K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 18, 2026 | 31.8K | $37.18 | $1.18M | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 17, 2026 | 284.7K | $3.85 | $1.10M | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 17, 2026 | 284.7K | $36.25 | $10.32M | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Vest | Aug 14, 2026 | 243.2K | $3.85 | $936K | Form 4 ↗ |
Sukhatme Mayukh President & CIO | Sell | Aug 14, 2026 | 243.2K | $36.23 | $8.81M | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Vest | Jul 27, 2026 | 200.0K | $3.85 | $770K | Form 4 ↗ |
Venker Eric President & Immunovant CEO | Sell | Jul 27, 2026 | 200.0K | $34.95 | $6.99M | Form 4 ↗ |
MOMTAZEE JAMES C Insider | Grant | Jul 17, 2026 | 405 | $0.00 | $0 | Form 4 ↗ |
Epperly Melissa B, Insider | Grant | Jul 17, 2026 | 543 | $0.00 | $0 | Form 4 ↗ |
Oren Ilan Insider | Grant | Jul 17, 2026 | 775 | $0.00 | $0 | Form 4 ↗ |
Gline Matthew CEO | Sell tax | Jun 30, 2026 | 76.2K | $35.39 | $2.70M | Form 4 ↗ |
Fitzgerald Meghan Director | Vest | Jun 30, 2026 | 10.0K | $8.80 | $88K | Form 4 ↗ |
Fitzgerald Meghan Director | Sell | Jun 30, 2026 | 10.0K | $34.90 | $349K | Form 4 ↗ |
Torti Frank President and Vant Chair | Sell tax | Jun 30, 2026 | 40.3K | $35.39 | $1.43M | Form 4 ↗ |